logologo
QuantliQuantli

Insmed Inc

INSM

NASDAQ

Biotechnology

$123.74

USD

-2.59 (-2.05%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $28.45B

Volume 2.0M

Price Target

$170.00$207.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $207.00 and a min estimate of $170.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$187.75

-$23.9 vs prior

Implied Upside

+51.7%

-19.4% vs prior

Analyst Covering

4

-9 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

24%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0.7500 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Josh Schimmer

Evercore ISI Group

Buy

Maintained

1 week ago

Plus
Plus
Plus

Vamil Divan

Guggenheim

Buy

Reiterated

1 month ago

Plus
Plus
Plus

Jessica Fye

JP Morgan

Buy

Maintained

2 months ago

Plus
Plus
Plus

Leonid Timashev

RBC Capital

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RVMD

Revolution Medicines Inc

$203.71

+0.8%

NBIX

Neurocrine Biosciences Inc

$152.72

+1.3%

UTHR

United Therapeutics Corp

$499.73

-0.3%

BIIB

Biogen Inc

$209.83

-0.4%

ALNY

Alnylam Pharmaceuticals Inc

$228.65

+0.7%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

MRNA

Moderna Inc

$63.32

-0.5%

INCY

Incyte Corp

$120.16

-0.3%

NTRA

Natera Inc

$309.93

-0.3%